Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / General / General / July 2005

Tip: Looking for answers? Try searching our database.

drug marketing upstaging science

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
outrider - 09 Jul 2005 02:03 GMT
Drug marketing is upstaging science

Advertising is an effective business tool. It sells products. That's
why companies spend billions of dollars each year on drug marketing
budgets - a lot more than is spent on drug research and development.

by Ellen Reynolds
June 27, 2005

It seems that even when we do know history, we're destined to repeat
it.

In 1948, diethylstilbestrol (DES) was advertised as the "wonder
drug" recommended for all pregnancies. The smiling face of a cherubic
infant peered out from the pages of medical journals next to the
caption "Really? Yes, desPLEX to prevent abortion, miscarriage and
premature labour...bigger and stronger babies too."

Advertising works. It worked for DES, which was prescribed to an
estimated 200,000 to 400,000 pregnant women in Canada between 1941 and
1971. Despite scientific evidence from 1952 that proved DES did not
prevent miscarriage, this harmful drug was advertised and prescribed
for 18 more years.

Only after it was linked to cancer in the daughters of women prescribed
DES was it finally restricted for use in pregnancy. Those exposed to
DES continue to face the effects of infertility, reproductive
abnormalities and cancer decades after initial exposure.

But that was over 30 years ago. Surely we've learned that prescription
drug advertising needs careful regulation. Apparently not.

We only have to look at the recent news surrounding the arthritis drug
Vioxx that is credited with causing thousands of extra heart attack
deaths. During its five years on the market, its manufacturer, Merck,
spent around US $500 million advertising the drug to the U.S. public.
Vioxx was no more effective than other similar drugs to treat arthritis
symptoms, it was a lot more expensive, and turned out to be much less
safe.

We've just observed DES Awareness Week - June 20 to 26. It's time to
remember the DES legacy, including the lesson that prescription drug
marketing cannot continue to upstage science.

Back in the '50s and '60s, doctors were the target for most drug
advertising. Direct-to-consumer advertising of prescription drugs
wasn't permitted in any form in Canada. We can only imagine how many
more people would have been exposed to DES if it had been promoted on
television, billboards, bus shelters, newspapers and magazines as
prescription drugs are today.

What many people don't realize is that direct-to-consumer advertising
is still illegal in Canada, as it is in almost all industrialized
countries of the world, with the exception of the United States and New
Zealand. The reason we are bombarded with drug advertising in this
country is that Health Canada isn't adequately enforcing the law and
companies have rushed to take advantage of this situation.

Most of us have seen the ads that slip past the border in American
magazines and on cable television. But prescription drug ads created
for a Canadian audience are slightly different. A 1978 amendment to the
Food and Drugs Act was introduced to allow consumers to compare drug
prices. Advertisers were permitted to post the drug's name, price and
quantity as long as they made "no other representations."

However, in November 2000, citing the 1978 price advertising clause,
Health Canada published a policy paper saying that companies could
advertise prescription drugs as long as they didn't include the drug's
name and information on its intended use in the same ad. The law hadn't
changed - just its interpretation. Needless to say, drug companies
are taking advantage of this legal loophole to introduce more and more
direct-to-consumer advertising. And Health Canada is letting it happen.

So we see "help-seeking ads" that encourage the public to call a
1-800 number if they're suffering from obesity, high blood pressure,
high cholesterol, erectile dysfunction, etc. Or branded ads that name a
drug but don't refer directly to the condition it treats - such as
the not-so-subtle Viagra ads which feature its recognizable brand
coupled with a heavy dose of sexual innuendo. Neither type of ad fits
with the intent of the Food and Drugs Act.

In April 2004 in the report Opening the Medicine Cabinet, the Standing
Committee on Health admonished Health Canada for a lack of enforcement
and vigilance. Among other recommendations to increase transparency and
improve post-market surveillance of prescription drugs, the Committee
stated that Health Canada should enforce The Food and Drugs Act by
enforcing the ban on direct-to-consumer drug advertising.

Yet, as part of the current legislative renewal process at Health
Canada, the department is proposing the exact opposite - legalization
of direct-to-consumer advertising of prescription drugs as a form of
public "information."

Advertising is an effective business tool. It sells products. That's
why companies spend billions of dollars each year on drug marketing
budgets - a lot more than is spent on drug research and development.
But advertising does not provide reliable public information.
Prescription drug ads are often misleading. They downplay the risks,
exaggerate benefits and imply that drugs may be used to treat a wider
range of conditions than they are approved to treat.

The ads also focus mainly on the newest drugs available - drugs that
are usually more expensive and not necessarily the most effective or
safest choice. The Vioxx example proves the point once again. With
celebrity endorsements, free trial offers, and emotive imagery
suggesting complete relief, was the public really being "informed"
or "educated"?

Let's call a spade a shovel and quit heaping illegal advertising down
the throats of Canadians who are simply looking for reliable drug
information. Let's learn from the mistakes of the past and take our cue
from most other industrialized nations of the world where
direct-to-consumer advertising continues to be illegal. Look to the
European Parliament where an attempt to introduce direct-to-consumer
advertising in 2002 was soundly rejected in the name of public health.

Parliamentarians voted overwhelmingly against legalizing
direct-to-consumer advertising and stated that the pharmaceutical
industry was "incapable of providing impartial information on its
medicines." When will Health Canada come to the same logical
conclusion? It's time to stop this drive to legalize direct-to-consumer
advertising of prescription drugs in Canada - before it's a done
deal.

Ellen Reynolds is project coordinator at DES Action Canada and lives in
Victoria, B.C. With background from Dr. Barbara Mintzes, drug
researcher and vice-president of DES Action Canada

Fair Use
Barry - 09 Jul 2005 03:09 GMT
Here again is some information about "fair dealing" in Canada from
http://en.wikipedia.org/wiki/Fair_dealing#Fair_dealing_in_Canada. I'll
go over each item this time. My comments are after each ###.

Six principal criteria for evaluating fair use:

1. The Purpose of the Dealing Is it for research, private study,
criticism, review or news reporting? It expresses that "these allowable

purposes should not be given a restrictive interpretation or this could

result in the undue restriction of users' rights."

### That covers a lot. Like just about everything that's published.
This criteria makes it sound like these are just small sections of the
law and not as complete as the American list that was posted. But based
on this wording, I'll give you the benefit of the doubt.

2. The Character of the Dealing How are the works were dealt with? Was
there a single or multiple copies. Were these copies distributed widely

or to a limited group of people? Was the copy destroyed after its
purpose was accomplished? What are the normal practices of the
industry?

### Number two is against you.

3. The Amount of the Dealing How much of the work was used? What was
the importance of the infringed work? Quoting trivial amounts may alone

sufficiently establish fair dealing. In some cases even quoting the
entire work may be fair dealing.

### Leans against you, but I'll ignore this one.

4. Alternatives to the Dealing Was a "non-copyrighted equivalent of the

work" available to the user? Could the work have been properly
criticized without being copied?

### Against you

5. The Nature of the Work Copying from a work that has never been
published could be more fair than from a published work "in that its
reproduction with acknowledgement could lead to a wider public
dissemination of the work - one of the goals of copyright law. If,
however, the work in question was confidential, this may tip the scales

towards finding that the dealing was unfair."

### It's been published, you this one won't help you.

6. Effect of the Dealing on the Work Is it likely to affect the market
of the original work? "Although the effect of the dealing on the market

of the copyright owner is an important factor, it is neither the only
factor nor the most important factor that a court must consider in
deciding if the dealing is fair." A statement that a dealing infringes
may not be sufficient, but evidence will often be required.

### As I've said, the webpage you took it from contains Google ads, and
you didn't even provide a link or url of that page. Number six is
against you.

"These factors may be more or less relevant to assessing the fairness
of a dealing depending on the factual context of the allegedly
infringing dealing. In some contexts, there may be factors other than
those listed here that may help a court decide whether the dealing was
fair."
outrider - 09 Jul 2005 03:40 GMT
> Here again is some information about "fair dealing" in Canada from
> http://en.wikipedia.org/wiki/Fair_dealing#Fair_dealing_in_Canada. I'll
[quoted text clipped - 65 lines]
> those listed here that may help a court decide whether the dealing was
> fair."

Do you think the DES example was a valid one in the context of today's
drug marketing practises?

Zee
Barry - 09 Jul 2005 06:35 GMT
Without reading or researching the article, I'll just say that all
industries are corrupt and I'm generally in favor of more government
oversight.

Ok, I did read the top part that says "Advertising is an effective
business tool. It sells products. That's why companies spend billions
of dollars each year on drug marketing budgets - a lot more than is
spent on drug research and development."

Even if the drug industry is an exception to my corrupt industry rule,
you have to expect them to run it like a business, with profit being
their primary concern, as long as they obey the rules and aren't
deceiving or sleazy in some way or other. Spending more on marketing
than R&D doesn't make them bad in my opinion. People can actually
benefit from marketing. A doctor might get free medication and pass the
savings on to his patients. Someone might be too ashamed to ask his
doctor about a sex problem until he hears Bob Dole being brave and
saying Viagra works. Whether drug companies should be allowed to spend
money on marketing to the extent and in all the ways they are, I don't
know, but money motivates people to be productive and maybe the real
problem is that people aren't donating enough money to medical
charities.
Terri - 10 Jul 2005 11:24 GMT
> Here again is some information about "fair dealing" in Canada from
> http://en.wikipedia.org/wiki/Fair_dealing#Fair_dealing_in_Canada. I'll
[quoted text clipped - 22 lines]
>
> ### Number two is against you.

No it isn't. The original was free to the public. And it had an infinite
number of copies which were also free.

> 3. The Amount of the Dealing How much of the work was used? What was
> the importance of the infringed work? Quoting trivial amounts may alone
[quoted text clipped - 3 lines]
>
> ### Leans against you, but I'll ignore this one.

This one supports.

> 4. Alternatives to the Dealing Was a "non-copyrighted equivalent of the
>
> work" available to the user? Could the work have been properly
> criticized without being copied?
>
> ### Against you

No. Full discussion requires that everyone engaging in the discussion
have the full text of the work in question. For many reasons, posting
the full text might frequently be the only way to accomplish that goal.

> 5. The Nature of the Work Copying from a work that has never been
> published could be more fair than from a published work "in that its
[quoted text clipped - 5 lines]
>
> ### It's been published, you this one won't help you.

In a format that makes it freely available to anyone with a computer and
the right software.

> 6. Effect of the Dealing on the Work Is it likely to affect the market
> of the original work? "Although the effect of the dealing on the market
[quoted text clipped - 7 lines]
> you didn't even provide a link or url of that page. Number six is
> against you.

If you don't click on and read every google ad that appeared you stole
your reading too.

> "These factors may be more or less relevant to assessing the fairness
> of a dealing depending on the factual context of the allegedly
> infringing dealing. In some contexts, there may be factors other than
> those listed here that may help a court decide whether the dealing was
> fair."

You've merely highlighted the absurdity of trying to use copyright laws
intended for older technology (paper and ink) and applying them to
electronic publications.
Barry - 10 Jul 2005 22:10 GMT
(Sorry if this is a duplicate. My first reply didn't show up in
Google.)

> > 2. The Character of the Dealing How are the works were dealt with? Was
> > there a single or multiple copies. Were these copies distributed widely
[quoted text clipped - 6 lines]
> No it isn't. The original was free to the public. And it had an infinite
> number of copies which were also free.

I'm pretty sure that criteria 2 is about the reuse of the original. The
reused version was made public to a large audience and gets archived by
Google. It's not destroyed. It's against her.

> > 3. The Amount of the Dealing How much of the work was used? What was
> > the importance of the infringed work? Quoting trivial amounts may alone
[quoted text clipped - 4 lines]
>
> This one supports.

Everything was used: against her. Importance of work: Not sure how they
mean that. Quoting everything is made to sound unlikely to be
acceptible. I'm being kind to not hold this against her, but I'm not
counting this in her favor.

> > 4. Alternatives to the Dealing Was a "non-copyrighted equivalent of the
> > work" available to the user? Could the work have been properly
[quoted text clipped - 5 lines]
> have the full text of the work in question. For many reasons, posting
> the full text might frequently be the only way to accomplish that goal.

Most criticism isn't done by the general public, and criticism by the
reuser is probably what number 4 refers to, but either way, a link
alone could have been provided.

> > 5. The Nature of the Work Copying from a work that has never been
> > published could be more fair than from a published work "in that its
[quoted text clipped - 7 lines]
> In a format that makes it freely available to anyone with a computer and
> the right software.

Yes, so--as stated in number 5--reproduction, especially without full
acknowledgement (no link to the source), won't lead to as much of an
increase in "public dissemination" as it would if the original work
wasn't as freely available. The last part about the work being
confidential isn't against her, but the rest is more against her than
for her. Again, I was kind not to hold it against her. I interpreted
number 5 as only having the ability to help her, but it doesn't in her
case.

> > 6. Effect of the Dealing on the Work Is it likely to affect the market
> > of the original work? "Although the effect of the dealing on the market
[quoted text clipped - 9 lines]
> If you don't click on and read every google ad that appeared you stole
> your reading too.

Yeah, right.
outrider - 11 Jul 2005 06:18 GMT
What if....the writer gave the article to the poster, and it wasn't
taken off a website at all?

Zee
Barry - 11 Jul 2005 09:10 GMT
> What if....the writer gave the article to the poster, and it wasn't
> taken off a website at all?

Depends who owned the rights and what rights they were. If you were
"given" the article by some with the right to grant republication
rights to you, then it depends on the terms of the agreement.

By claiming "fair use" you're essentially admitting that you don't have
the right to republish the article outside of the fair use rules,
though it might be Canada's fair dealing rules that apply. I doubt
you'd claim "fair use" if you had full republication rights from the
owner.

Some information on different rights someone might have to copyrighted
material is at http://www.writing-world.com/rights/rights.shtml :

"When a publication asks for exclusive rights, they are asking that the
piece not appear anywhere else while they are exercising their right to
it. There is often a limit on the length of time a publisher will
request exclusive rights -- one month, three months, one year -- and
then that piece may appear elsewhere.

"Nonexclusive is just the opposite; Publisher A may feature your piece
on their website for a year, but because their right to do so is
nonexclusive, you can sell the piece to Publisher B and have it appear
elsewhere at the same time. Just make sure Publisher B doesn't want
exclusivity!"
outrider - 12 Jul 2005 00:04 GMT
> > What if....the writer gave the article to the poster, and it wasn't
> > taken off a website at all?
[quoted text clipped - 23 lines]
> elsewhere at the same time. Just make sure Publisher B doesn't want
> exclusivity!"

What a lot of information. Thank you so much.

Zee
Carey Gregory - 12 Jul 2005 01:59 GMT
>What if....the writer gave the article to the poster, and it wasn't
>taken off a website at all?

Then it's customary to add the words, "Reprinted with permission of the
author."
Kurt Ullman - 12 Jul 2005 03:14 GMT
>>What if....the writer gave the article to the poster, and it wasn't
>>taken off a website at all?
>
>Then it's customary to add the words, "Reprinted with permission of the
>author."

     Customary but not required. Also be reminded that giving the
article would not necessarily mean it can posted at will. For
instance, he or she may have given permission to use it on a
website, absent specific information to the contrary, the assumption
is that permission WASN"T granted to use it in a magazine or put it
on a CD as a compilation or use it as the basis for a screenplay,
etc.

--
    "Even I realized that money was to politicians what the
ecalyptus tree is to koala bears: food, water, shelter and something to crap on."
---PJ O'Rourke
Carey Gregory - 13 Jul 2005 07:39 GMT
>Customary but not required. Also be reminded that giving the
>article would not necessarily mean it can posted at will.

Well, I do believe I said customary but did not say required.  And you're
completely right, of course, that simply giving someone an article isn't
permission to reprint.

Be that as it may, if the claim all of a sudden now is that the article was
posted with permission, then I call complete bullshit.  That would have been
stated long, long ago were it true.  
Kurt Ullman - 13 Jul 2005 13:25 GMT
>Be that as it may, if the claim all of a sudden now is that the article was
>posted with permission, then I call complete bullshit.  That would have been
>stated long, long ago were it true.  

     And the defense of it being "Fair Use" would have been much
less spirited (g).

--
    "Even I realized that money was to politicians what the
ecalyptus tree is to koala bears: food, water, shelter and something to crap on."
---PJ O'Rourke
outrider - 13 Jul 2005 22:53 GMT
> >Be that as it may, if the claim all of a sudden now is that the article was
> >posted with permission, then I call complete bullshit.  That would have been
[quoted text clipped - 7 lines]
> ecalyptus tree is to koala bears: food, water, shelter and something to crap on."
>  ---PJ O'Rourke

Here ya go boyo:

oycotting is my new drug of choice

by Heather Mallick
July 3, 2005

http://www.rabble.ca/columnist s_full.shtml?x=40213

Like most of us, I spent my youth in thrall to "the toxic drive"
- the human need to alter reality artificially. For others who stick
with the thrall as they age, it's cigarettes, or beer. Wealthier people
choose The Macallan. But in those days, when I was offered a pill I
would just say yes.

The childhood roots of this were my doctor-father's entrancing,
corruptive medical magazines with their ads for pharmaceuticals to cure
ills I couldn't pronounce. Drugs could never harm, only heal, I
thought, and though I wasn't as blasé as those people who take their
pet's medications when they can't be bothered to see a doctor ("Hey,
an antibiotic is an antibiotic, right?"), in adulthood it was
pleasing to feel a drug smash the bacteria, sometimes within minutes.

In Grade 2, I remember illustrating a class project with a cover from
Life magazine showing a stylized human body packed with
hallucinogenically beautiful capsules, like little sorbets. I got an A.
It is chilling to think I nursed this taste in the sixties when drugs
like thalidomide and diethylstilbestrol were being casually prescribed
to obedient women.

How times have changed, along with my enthusiasms. Having given up
illegal drugs, I have begun trying to clear legal but possibly
untrustworthy medications from my innards.

The great pharmaceutical firms began merging in the 1980s to keep their
share prices high, which made them treat their researchers like slaves
manning a Roman galley. Like the big record labels, Big Pharma is only
as good as its hottest product, expensive to devise and promote.

This explains why Britney Spears defines today's music industry and
anti-depressants and bio-sex drugs define Big Pharma. (Levitra, the
latest, has a penis-on-fire logo that looks like an illustration in a
teen sex pamphlet.) Now Viagra has been linked to blindness and an
anti-depressant called Seroxtat has been said to make people kill
themselves rather than cheering them up. Drugs are sent to market
without long-term testing, with permission from a government that
hungers for their campaign contributions. Yes, it has come to this
sorry pass: Me, clean and sober. (I used to drink only French wine. I
have now decided I should only drink wine in France.)

What shocked me into it was the latest news about autism. British
parents had begun to suspect that the MMR shot, three vaccines in one,
was responsible for the increase in autism. Corporations and
governments said pish posh, what nonsense, and the issue faded.

Now Robert F. Kennedy Jr. says the villain was the 1991 introduction of
thimerosal, a mercury-based additive that preserved vaccines and made
them more profitable for Big Pharma to inject en masse. It now seems
that the mercury (especially in a triple dose) did terrible things to
developing infant brains. Why would anyone have thought it would not,
one wonders.

He says this is why the odious U.S. Senator Bill Frist this year added
to an anti-terrorism bill a rider that bans compensation for children
brain-damaged by thimerosal in vaccines, and actually devised something
called the "Eli Lilly Protection Act." (In Canada, thimerosal does
remain in some vaccines. Google "thimerosal" to obtain the Public
Health Agency of Canada's June statement on this.)

The scandal gets worse and more complicated, but the reasoning behind
concealing Big Pharma misdeeds apparently is that if millions of
children in the West and in poor countries, where the leftover tainted
vaccines have been sent, were poisoned, the industry would go under. It
would be Thalidomide II: Bankruptcy.

Read Irvine Welsh's prescient 1996 short story Fortune's Always Hiding:
A Corporate Drug Romance, in which a thalidomide executive retires to
Bavaria with his wife and new baby. He has secrets, shall we say, but
their life is content. One day, the baby is . . . gone. A parcel
arrives. It contains two baby arms. No one can comprehend such a thing.
But the father? He goes into the garage and blows his head off with a
shotgun. He knows what he did to keep thalidomide selling.

Thalidomide is back. It is said to help treat leprosy, Mantle cell
lymphoma and pancreatic cancer. A year ago, a baby was born in Kenya
without arms and legs. Thalidomide is being used in Kenya. The parents
say their son Freddie is the only victim to appear because babies like
him are killed at birth. Freddie sits in a baby chair shaped like a
flower pot.

It's the confluence of stories about the hideous effects of
inadequately tested drugs that has turned me against pharmaceuticals.
Big Pharma, in partnership with docile governments, is getting its way
because both bow to the pressures of the market. If ever there were an
unacceptable face of capitalism, this is it.

This month, I began withdrawing my bank savings, for inflation meant I
was losing money daily. I will find a faintly profitable place to stash
them, but I should mention that when I was shown glossy mutual funds
with excellent rates of return, they were filled with Big Pharma, with
the banks I had just deserted, and companies such as Nestlé that I
have boycotted for years.

For this is my substitute, my new habit. I have become a boycotter. I
don't buy American goods if I can avoid it, never buy from big Bush
donors, only buy Fairtrade food and organic food so that farmers aren't
forced to buy genetically modified seeds, and so on.

It's intellectually absorbing, this boycott habit of mine, though not
nearly as much fun as filling my young body with drugs without thought
for the morrow. 'Tis a thin gruel to feed the toxic drive. But it has
its own satisfactions.

fairuse
Kurt Ullman - 13 Jul 2005 23:02 GMT
>>       And the defense of it being "Fair Use" would have been much
>> less spirited (g).
>>
>> --

>Here ya go boyo:
>
>oycotting is my new drug of choice
   <Snipped yet another big stolen piece that had absolutely
nothing to do with the argument at hand>

Well that certainly put me in my place.

--
    "Even I realized that money was to politicians what the
ecalyptus tree is to koala bears: food, water, shelter and something to crap on."
---PJ O'Rourke
outrider - 13 Jul 2005 23:54 GMT
> >>       And the defense of it being "Fair Use" would have been much
> >> less spirited (g).
[quoted text clipped - 13 lines]
> ecalyptus tree is to koala bears: food, water, shelter and something to crap on."
>  ---PJ O'Rourke

 <Snipped yet another big stolen piece that had absolutely
> nothing to do with the argument at hand>

Which began, oh...here abouts:

http://groups.google.ca/group/sci.med/msg/0ef2da779d55028d?dmode=source&hl=en
Kurt Ullman - 14 Jul 2005 00:02 GMT
>> >>       And the defense of it being "Fair Use" would have been much
>> >> less spirited (g).
[quoted text clipped - 8 lines]
>>
>>  Well that certainly put me in my place.

>  <Snipped yet another big stolen piece that had absolutely
>> nothing to do with the argument at hand>
>
>Which began, oh...here abouts:
>
>http://groups.google.ca/group/sci.med/msg/0ef2da779d55028d?dmode=source&hl=en

 With me being absolutely correct and right even about you
violating copyrights, a practice you still feel obligated to
continued.
   I am, yet again, so put in place.
BTW: Your last missive STILL had nothing to do with the argument at
hand, which you so brilliantly confirm with the above link.

--
    "Even I realized that money was to politicians what the
ecalyptus tree is to koala bears: food, water, shelter and something to crap on."
---PJ O'Rourke
outrider - 14 Jul 2005 00:17 GMT
Well you'll have to excuse me Kurt. I have a deadline.

Carry on....

Zee
Kurt Ullman - 14 Jul 2005 02:56 GMT
>Well you'll have to excuse me Kurt. I have a deadline.

   You only have a short period of time to steal someone else's
work?

--
    "Even I realized that money was to politicians what the
ecalyptus tree is to koala bears: food, water, shelter and something to crap on."
---PJ O'Rourke
outrider - 14 Jul 2005 05:11 GMT
<<lol>>

> >Well you'll have to excuse me Kurt. I have a deadline.
> >
[quoted text clipped - 5 lines]
> ecalyptus tree is to koala bears: food, water, shelter and something to crap on."
>  ---PJ O'Rourke
outrider - 14 Jul 2005 19:53 GMT
> >Well you'll have to excuse me Kurt. I have a deadline.
> >
[quoted text clipped - 5 lines]
> ecalyptus tree is to koala bears: food, water, shelter and something to crap on."
>  ---PJ O'Rourke

Why not let Roman hear your thoughts about fair use, and his
contravening of same?

Please be sure to post his responses.

http://groups.google.ca/group/sci.med/msg/bd2b04ded5bd69c9?hl=en&
David Wright - 21 Jul 2005 03:46 GMT
>> >Be that as it may, if the claim all of a sudden now is that the article was
>> >posted with permission, then I call complete bullshit.  That would have been
[quoted text clipped - 12 lines]
>
>oycotting is my new drug of choice

Oycotting?  Is this some sort of Yiddish thing?

>by Heather Mallick
>July 3, 2005
[quoted text clipped - 7 lines]
>like thalidomide and diethylstilbestrol were being casually prescribed
>to obedient women.

Not in the US.  No thalidomide in the 60s.  Canada, maybe.

>What shocked me into it was the latest news about autism. British
>parents had begun to suspect that the MMR shot, three vaccines in one,
>was responsible for the increase in autism. Corporations and
>governments said pish posh, what nonsense, and the issue faded.

Like hell it did.  It's alive and well in the UK and causing
epidemics.

>Now Robert F. Kennedy Jr. says the villain was the 1991 introduction of
>thimerosal, a mercury-based additive that preserved vaccines and made
>them more profitable for Big Pharma to inject en masse. It now seems
>that the mercury (especially in a triple dose) did terrible things to
>developing infant brains. Why would anyone have thought it would not,
>one wonders.

Why anyone thinks thimerosal first appeared in 1991 is beyond me.

>Thalidomide is back. It is said to help treat leprosy, Mantle cell
>lymphoma and pancreatic cancer.

It's useful, too.  But that doesn't excuse giving it to pregnant
women.

 -- David Wright :: alphabeta at prodigy.net
    These are my opinions only, but they're almost always correct.
    "I believe that sex is one of the most beautiful, wholesome and
     natural things that money can buy."
                                       -- Steve Martin
outrider - 21 Jul 2005 06:15 GMT
She did get some dates and points wrong. I generally like Mallick, not
necessarily because I agree with everything she says. But that's not
why I post any of the writings which I post.

I post Mallick because I think she's a terrific stylist, is thought
provoking, and tackles topics in a refreshing way. But having worked a
news desk, I know how hard it it to meet daily deadlines, and get
something wrong when you didn't think you had.

Thank you for giving me something to respond to David.

Zee
bae@cs.toronto.no-uce.edu - 21 Jul 2005 15:13 GMT
>She did get some dates and points wrong. I generally like Mallick, not
>necessarily because I agree with everything she says. But that's not
[quoted text clipped - 4 lines]
>news desk, I know how hard it it to meet daily deadlines, and get
>something wrong when you didn't think you had.

Personally, I'd rather have information that's correct rather than crap
presented misleadingly with good writing style.  

While the article you stole is nicely written, it has flaws not only in
fact but in logic.  If she were writing about fashion or sports or some
other topic that doesn't influence life and death decisions, that would
be fine with me.  In this case, it's irresponsible.  It takes more than
good writing style to make a good science and medicine reporter.  It's
not an easy job, but it's not an impossible one.

You might have stolen and posted the article to demonstrate what a very
bad job she's doing, but you say you did so for the opposite reason.

How would you feel about this terrific stylist if she wrote a thought
provoking article tackling the problems of aboriginal people in a
refreshing way, if what she advocated were odious to you?  Perhaps she
might suggest that all the social problems of reserves would be
eliminated if the people there were isolated from all mainstream
cultural influence, made to return to their original hunter-gatherer
lifestyle, complete with population control by starvation, disease, war
and infanticide in the traditional, natural manner.  Well, she can't be
bothered to actually learn any law or anthropology, or speak with
people who are more knowledgable than she is, but she's a terrific
stylist, thought provoking, and tackles topics in a refreshing way, so
any influence she has on people's views and opinions is just fine with
you, and we should all applaud her talent.  Right?
outrider - 21 Jul 2005 16:12 GMT
> >She did get some dates and points wrong. I generally like Mallick, not
> >necessarily because I agree with everything she says. But that's not
[quoted text clipped - 7 lines]
> Personally, I'd rather have information that's correct rather than crap
> presented misleadingly with good writing style.

Information that is correct? Would that be say, the medical information
done in the '60s and '70s which is now proven 'wrong'?

This is a column. It is opinion. Perhaps you don't know the difference.

> While the article you stole

Uhoh! B. makes errors too; both of fact, and judgement. The article is
not "stolen".

is nicely written, it has flaws not only in
> fact but in logic.  If she were writing about fashion or sports or some
> other topic that doesn't influence life and death decisions, that would
> be fine with me.  In this case, it's irresponsible.  It takes more than
> good writing style to make a good science and medicine reporter.  It's
> not an easy job, but it's not an impossible one.

I can agree with you there. And David was the first one to comment on
this. It was not commented on in a previous looooong thread. David did.
Kudos. I knew they were there. Did you, or are you just following
David?

> You might have stolen and posted the article to demonstrate what a very
> bad job she's doing, but you say you did so for the opposite reason.

I posted it to spur discussion, as I always hope will happen with the
articles I post. And I am on recored stating that. Just because I don't
take part in the discussion, doesn't mean I (and the authors of the
articles I post) don't enjoy reading your pithy comments.

> How would you feel about this terrific stylist if she wrote a thought
> provoking article tackling the problems of aboriginal people in a
[quoted text clipped - 4 lines]
> lifestyle, complete with population control by starvation, disease, war
> and infanticide in the traditional, natural manner.

You've been to my reserve?

Well, she can't be
> bothered to actually learn any law or anthropology, or speak with
> people who are more knowledgable than she is, but she's a terrific
> stylist, thought provoking, and tackles topics in a refreshing way, so
> any influence she has on people's views and opinions is just fine with
> you, and we should all applaud her talent.  Right?

Interesting comments. Thanks.
outrider - 13 Jul 2005 22:52 GMT
> >Customary but not required. Also be reminded that giving the
> >article would not necessarily mean it can posted at will.
[quoted text clipped - 6 lines]
> posted with permission, then I call complete bullshit.  That would have been
> stated long, long ago were it true.

Just for you Carey:

Boycotting is my new drug of choice

by Heather Mallick
July 3, 2005

http://www.rabble.ca/columnist s_full.shtml?x=40213

Like most of us, I spent my youth in thrall to "the toxic drive"
- the human need to alter reality artificially. For others who stick
with the thrall as they age, it's cigarettes, or beer. Wealthier people
choose The Macallan. But in those days, when I was offered a pill I
would just say yes.

The childhood roots of this were my doctor-father's entrancing,
corruptive medical magazines with their ads for pharmaceuticals to cure
ills I couldn't pronounce. Drugs could never harm, only heal, I
thought, and though I wasn't as blasé as those people who take their
pet's medications when they can't be bothered to see a doctor ("Hey,
an antibiotic is an antibiotic, right?"), in adulthood it was
pleasing to feel a drug smash the bacteria, sometimes within minutes.

In Grade 2, I remember illustrating a class project with a cover from
Life magazine showing a stylized human body packed with
hallucinogenically beautiful capsules, like little sorbets. I got an A.
It is chilling to think I nursed this taste in the sixties when drugs
like thalidomide and diethylstilbestrol were being casually prescribed
to obedient women.

How times have changed, along with my enthusiasms. Having given up
illegal drugs, I have begun trying to clear legal but possibly
untrustworthy medications from my innards.

The great pharmaceutical firms began merging in the 1980s to keep their
share prices high, which made them treat their researchers like slaves
manning a Roman galley. Like the big record labels, Big Pharma is only
as good as its hottest product, expensive to devise and promote.

This explains why Britney Spears defines today's music industry and
anti-depressants and bio-sex drugs define Big Pharma. (Levitra, the
latest, has a penis-on-fire logo that looks like an illustration in a
teen sex pamphlet.) Now Viagra has been linked to blindness and an
anti-depressant called Seroxtat has been said to make people kill
themselves rather than cheering them up. Drugs are sent to market
without long-term testing, with permission from a government that
hungers for their campaign contributions. Yes, it has come to this
sorry pass: Me, clean and sober. (I used to drink only French wine. I
have now decided I should only drink wine in France.)

What shocked me into it was the latest news about autism. British
parents had begun to suspect that the MMR shot, three vaccines in one,
was responsible for the increase in autism. Corporations and
governments said pish posh, what nonsense, and the issue faded.

Now Robert F. Kennedy Jr. says the villain was the 1991 introduction of
thimerosal, a mercury-based additive that preserved vaccines and made
them more profitable for Big Pharma to inject en masse. It now seems
that the mercury (especially in a triple dose) did terrible things to
developing infant brains. Why would anyone have thought it would not,
one wonders.

He says this is why the odious U.S. Senator Bill Frist this year added
to an anti-terrorism bill a rider that bans compensation for children
brain-damaged by thimerosal in vaccines, and actually devised something
called the "Eli Lilly Protection Act." (In Canada, thimerosal does
remain in some vaccines. Google "thimerosal" to obtain the Public
Health Agency of Canada's June statement on this.)

The scandal gets worse and more complicated, but the reasoning behind
concealing Big Pharma misdeeds apparently is that if millions of
children in the West and in poor countries, where the leftover tainted
vaccines have been sent, were poisoned, the industry would go under. It
would be Thalidomide II: Bankruptcy.

Read Irvine Welsh's prescient 1996 short story Fortune's Always Hiding:
A Corporate Drug Romance, in which a thalidomide executive retires to
Bavaria with his wife and new baby. He has secrets, shall we say, but
their life is content. One day, the baby is . . . gone. A parcel
arrives. It contains two baby arms. No one can comprehend such a thing.
But the father? He goes into the garage and blows his head off with a
shotgun. He knows what he did to keep thalidomide selling.

Thalidomide is back. It is said to help treat leprosy, Mantle cell
lymphoma and pancreatic cancer. A year ago, a baby was born in Kenya
without arms and legs. Thalidomide is being used in Kenya. The parents
say their son Freddie is the only victim to appear because babies like
him are killed at birth. Freddie sits in a baby chair shaped like a
flower pot.

It's the confluence of stories about the hideous effects of
inadequately tested drugs that has turned me against pharmaceuticals.
Big Pharma, in partnership with docile governments, is getting its way
because both bow to the pressures of the market. If ever there were an
unacceptable face of capitalism, this is it.

This month, I began withdrawing my bank savings, for inflation meant I
was losing money daily. I will find a faintly profitable place to stash
them, but I should mention that when I was shown glossy mutual funds
with excellent rates of return, they were filled with Big Pharma, with
the banks I had just deserted, and companies such as Nestlé that I
have boycotted for years.

For this is my substitute, my new habit. I have become a boycotter. I
don't buy American goods if I can avoid it, never buy from big Bush
donors, only buy Fairtrade food and organic food so that farmers aren't
forced to buy genetically modified seeds, and so on.

It's intellectually absorbing, this boycott habit of mine, though not
nearly as much fun as filling my young body with drugs without thought
for the morrow. 'Tis a thin gruel to feed the toxic drive. But it has
its own satisfactions.

fairuse
Carey Gregory - 18 Jul 2005 15:48 GMT
>Just for you Carey:
>
>Boycotting is my new drug of choice

Double posting off-topic stolen pieces seems to be your new drug of choice.
outrider - 18 Jul 2005 15:56 GMT
> >Just for you Carey:
> >
> >Boycotting is my new drug of choice
>
> Double posting off-topic stolen pieces seems to be your new drug of choice.

Why not let Roman hear your thoughts about fair use, and his
contravening of same?

Please be sure to post his response.

http://groups.google.ca/group/ sci.med/msg/bd2b04ded5bd69c9?h l=en&
Carey Gregory - 18 Jul 2005 18:46 GMT
>Why not let Roman hear your thoughts about fair use, and his
>contravening of same?
>
>Please be sure to post his response.

Why would I give a crap what he thinks?

>http://groups.google.ca/group/ sci.med/msg/bd2b04ded5bd69c9?h l=en&

Ah, I see.  He stole an article from the AP which you then stole from him.
How cute.

Oh, and the article is total fluff anyway.  Go figure that the press makes a
habit out of touting single-study results and misleading the public, and
then writes another article decrying single-study results.    Meanwhile,
scientists and doctors have always known this.  Duh.
Kurt Ullman - 18 Jul 2005 23:46 GMT
>Oh, and the article is total fluff anyway.  Go figure that the press makes a
>habit out of touting single-study results and misleading the public, and
>then writes another article decrying single-study results.    Meanwhile,
>scientists and doctors have always known this.  Duh.

       Actually it is even better than that. They are touting the
single-study results of a single study of single studies. The
circles here are endless.

--
    "No nation would be so dumb as to say that we all want to go one point,
we just don't know how to get there. What we are finding is some want to go to
San Diego, some to Seattle. We are ashamed to admit this so we
pretend we all want to go to San Francisco."
    Uwe Reinhardt on the health care debate.
Terri - 12 Jul 2005 11:54 GMT
>>What if....the writer gave the article to the poster, and it wasn't
>>taken off a website at all?
>
> Then it's customary to add the words, "Reprinted with permission of the
> author."

But not required.
 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2008 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.